home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9604b.zip
/
M9640569.TXT
< prev
next >
Wrap
Text File
|
1996-03-04
|
2KB
|
36 lines
Document 0569
DOCN M9640569
TI Rapid generation of antibodies against the HTLV-II external envelope
protein by growth of mouse plasmacytomas in SCID mice.
DT 9604
AU Li QX; Camerini D; Kuritzkes DR; Chen IS; Department of Microbiology and
Immunology, UCLA School of; Medicine 90095, USA.
SO Virology. 1995 Dec 20;214(2):680-4. Unique Identifier : AIDSLINE
MED/96130214
AB Recombinant human T-cell leukemia virus type II (HTLV-II) envelope
external glycoprotein, gp46-II, was expressed using a vaccinia virus
vector. A recombinant gp46-II fused to an epitope of the influenza virus
hemagglutinin, YPYDVPDYA, was purified by immunoaffinity chromatography.
The purified glycoprotein was used to immunize Balb/c mice, and
antibodies against gp46-II were detected by Western blot analysis and
syncytium inhibition assays. We transformed spleen cells from the
immunized mice by retroviral infection with ABL-MYC (psi 2) and
intraperitoneally transplanted the infected cells into syngeneic Balb/c
and severe combined immunodeficient (SCID) mice. The plasmacytomas
established ascitic tumors that produced antibodies directed against
HTLV-II gp46-II. Ascites developed more rapidly in SCID mice than in
normal syngeneic mice. This procedure provides a general means to
generate antibodies rapidly.
DE Amino Acid Sequence Animal Antibodies, Viral/*BIOSYNTHESIS/IMMUNOLOGY
Cell Line Cell Transformation, Viral Gene Products,
env/GENETICS/*IMMUNOLOGY Hemagglutinins, Viral/GENETICS/METABOLISM
Human HTLV-BLV Antigens/GENETICS/*IMMUNOLOGY Mice Mice, Inbred BALB C
Mice, SCID Molecular Sequence Data Plasmacytoma/*IMMUNOLOGY
Recombinant Fusion Proteins/IMMUNOLOGY Retroviridae Proteins,
Oncogenic/GENETICS/*IMMUNOLOGY Spleen/CYTOLOGY Support, Non-U.S. Gov't
Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).